As of 2026-10-02, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (24.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -229.7%.
The range of the Relative Valuation is (24.20) - (27.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 19.3x | 17.6x |
| Forward P/E multiples | 14.3x - 18.7x | 15.8x |
| Fair Price | (24.20) - (27.50) | (24.65) |
| Upside | -227.4% - -244.7% | -229.7% |
| Date | P/E |